Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Interest Coverage Ratio (2019 - 2025)

Revolution Medicines has reported Interest Coverage Ratio over the past 5 years, most recently at 47.57 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 47.57 for Q4 2025, up 44.4% from a year ago — trailing twelve months through Dec 2025 was 286.23 (up 321.55% YoY), and the annual figure for FY2025 was 6420.89, down 2254.09%.
  • Interest Coverage Ratio for Q4 2025 was 47.57 at Revolution Medicines, down from 27.59 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for RVMD hit a ceiling of 27.59 in Q3 2025 and a floor of 3116.42 in Q1 2021.
  • Median Interest Coverage Ratio over the past 3 years was 50.15 (2024), compared with a mean of 665.46.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 210.43% in 2021 and later skyrocketed 44.4% in 2025.
  • Revolution Medicines' Interest Coverage Ratio stood at 3116.42 in 2021, then skyrocketed by 97.25% to 85.57 in 2024, then skyrocketed by 44.4% to 47.57 in 2025.
  • The last three reported values for Interest Coverage Ratio were 47.57 (Q4 2025), 27.59 (Q3 2025), and 85.57 (Q4 2024) per Business Quant data.